# Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)

> **NCT05503147** · PHASE1 · UNKNOWN · sponsor: **Ove Andersen** · enrollment: 17 (estimated)

## Conditions studied

- Malnutrition
- Anorexia
- Cannabis
- Aging
- Emergency Service, Hospital
- Renal Function
- Pharmacokinetics

## Interventions

- **DRUG:** Sativex

## Key facts

- **NCT ID:** NCT05503147
- **Lead sponsor:** Ove Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-24
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05503147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05503147, "Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05503147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*